Additionally, imidazobenzoxazine-5-thione (MV1035) inhibited the demethylation activity of ALKBH5 by competing with the 2OG active site, ultimately suppressing the migration and invasion of GBM cells [116,117]. Here, ALKBH5 is linked to glioblastoma.